Aging Analysis Reveals Slowed Tau Turnover and Enhanced Stress Response in a Mouse Model of Tauopathy

被引:66
作者
Dickey, Chad [1 ]
Kraft, Clara [1 ]
Jinwal, Umesh [1 ]
Koren, John [1 ]
Johnson, Amelia [1 ]
Anderson, Laura [1 ]
Lebson, Lori [1 ]
Lee, Daniel [1 ]
Dickson, Dennis [2 ]
de Silva, Rohan [3 ]
Binder, Lester I. [4 ]
Morgan, David [1 ]
Lewis, Jada [2 ]
机构
[1] Univ S Florida, Johnnie B Byrd Sr Alzheimers Inst, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA
[2] Mayo Clin Jacksonville, Dept Neurosci, Jacksonville, FL 32224 USA
[3] UCL, Inst Neurol, Reta Lila Weston Inst, London, England
[4] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA
基金
英国医学研究理事会;
关键词
ALZHEIMERS-DISEASE; MESSENGER-RNA; PATHOLOGICAL TAU; PROTEIN-KINASE; P301L TAU; CHIP; NEURONS; PHOSPHORYLATION; ACCUMULATION; IMPAIRMENT;
D O I
10.2353/ajpath.2009.080764
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We have extensively analyzed the biochemical and histochemical profiles of the tau protein from the rTg4510 transgenic mouse model in which the animals uniquely develop forebrain tau pathologies similar to those found in human tauopathies. Levels of several soluble phosphorylated tau species were highest at I month relative to later time points, suggesting that certain tau hyperphosphorylation events were insufficient to drive tangle formation in young mice. Despite a robust, pre-tangle-like accumulation of phospho-tau in 1-month-old mice, this material was cleared by 3 months, indicating that the young mouse brain either fails to facilitate tau insolubility or possesses an enhanced ability to clear tau relative to the adult. We also found that white heat shock protein expression increased with normal aging, this process was accelerated in rTg4510 mice. Moreover, by exploiting an exon 10 (-) specific antibody, we demonstrated that endogenous mouse tau turnover was slowed in response to human tau over-expression, and that this endogenous tau adopted disease-related properties. These data suggest that a younger brain fails to develop lasting tau pathology despite elevated levels of phosphorylated tau, perhaps because of reduced expression of stress-related proteins. Moreover, we show that the active production of small amounts of abnormal tau protein facilitates dysfunction and accumulation of otherwise normal tau, a significant implication for the pathogenesis of patients with Alzheimer's disease. (Am J Pathol 2009,174:228-238; DOI: 10.2353/ajpath.2009.080764)
引用
收藏
页码:228 / 238
页数:11
相关论文
共 44 条
  • [1] Ballinger CA, 1999, MOL CELL BIOL, V19, P4535
  • [2] Accumulation of pathological tau species and memory loss in a conditional model of tauopathy
    Berger, Zdenek
    Roder, Hanno
    Hanna, Amanda
    Carlson, Aaron
    Rangachari, Vijayaraghavan
    Yue, Mei
    Wszolek, Zbigniew
    Ashe, Karen
    Knight, Joshua
    Dickson, Dennis
    Andorfer, Cathy
    Rosenberry, Terrone L.
    Lewis, Jada
    Hutton, Mike
    Janus, Christopher
    [J]. JOURNAL OF NEUROSCIENCE, 2007, 27 (14) : 3650 - 3662
  • [3] Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity
    Biernat, J
    Wu, YZ
    Timm, T
    Zheng-Fischhöfer, QY
    Mandelkow, E
    Meijer, L
    Mandelkow, EM
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2002, 13 (11) : 4013 - 4028
  • [4] DISTRIBUTION OF THE PHOSPHORYLATED MICROTUBULE-ASSOCIATED PROTEIN-TAU IN DEVELOPING CORTICAL-NEURONS
    BRION, JP
    OCTAVE, JN
    COUCK, AM
    [J]. NEUROSCIENCE, 1994, 63 (03) : 895 - 909
  • [5] INHIBITION OF NEURITE POLARITY BY TAU ANTISENSE OLIGONUCLEOTIDES IN PRIMARY CEREBELLAR NEURONS
    CACERES, A
    KOSIK, KS
    [J]. NATURE, 1990, 343 (6257) : 461 - 463
  • [6] The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology
    Carmel, G
    Mager, EM
    Binder, LI
    Kuret, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (51) : 32789 - 32795
  • [7] Developmentally regulated alternative splicing of mRNAs encoding N-terminal tau variants in the rat hippocampus: Structural and functional implications
    Collet, J
    Ferhat, L
    Pollard, H
    de Pouplana, LR
    Charton, G
    Bernard, A
    Moreau, J
    Ben-Ari, Y
    Khrestchatisky, M
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1997, 9 (12) : 2723 - 2733
  • [8] Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies
    de Silva, R
    Lashley, T
    Gibb, G
    Hanger, D
    Hope, A
    Reid, A
    Bandopadhyay, R
    Utton, M
    Strand, C
    Jowett, T
    Khan, N
    Anderton, B
    Wood, N
    Holton, J
    Revesz, T
    Lees, A
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2003, 29 (03) : 288 - 302
  • [9] Akt and CHIP coregulate tau degradation through coordinated interactions
    Dickey, Chad A.
    Koren, John
    Zhang, Yong-Jie
    Xu, Ya-Fei
    Jinwal, Umesh K.
    Birnbaum, Morris J.
    Monks, Bobby
    Sun, Mei
    Cheng, An Q.
    Pattersonl, Cam
    Bailey, Rachel M.
    Dunmore, Judith
    Soresh, Sareh
    Leon, Carlos
    Morgan, Dave
    Petrucelli, Leonard
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (09) : 3622 - 3627
  • [10] The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins
    Dickey, Chad A.
    Kamal, Adeela
    Lundgren, Karen
    Klosak, Natalia
    Bailey, Rachel M.
    Dunmore, Judith
    Ash, Peter
    Shoraka, Sareh
    Zlatkovic, Jelena
    Eckman, Christopher B.
    Patterson, Cam
    Dickson, Dennis W.
    Nahman, N. Stanley, Jr.
    Hutton, Michael
    Burrows, Francis
    Petrucelli, Leonard
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (03) : 648 - 658